Gilead raked in $2.8 billion from remdesivir in 2020

Retrieved on: 2021-02-05 11:37:30

Tags for this article:

World War II

Nazi SS

Stutthof concentration camp

Oskar Gröning

Auschwitz concentration camp

Kapo

Operation Last Chance

Click the tags to see associated articles and topics

Gilead raked in $2.8 billion from remdesivir in 2020. View article details on hiswai:

Excerpt

Gilead Sciences collected $2.8 billion of revenue in 2020 from its IV coronavirus treatment Veklury, also known as remdesivir. The big picture: The ...

Article found on: www.axios.com

View Original Article